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Laying hensCardiovascular disease is a major cause of death worldwide, so people are advised to limit their intake of dietary
cholesterol [1]. Egg consumption has been seriously reduced because of the high levels of cholesterol [2]. The
objective of this study was to evaluate the cholesterol metabolism effects of alfalfa saponin extract (ASE) in
liver and ovary tissues using digital gene-expression (DGE) proﬁling analysis. The liver and ovary tissues were
isolated from laying hens fed with ASE for RNA sequencing. Here, we provide detailed experimental methods
and analysis pipeline in our study to identify digital gene expression of alfalfa saponin extract on laying hens
and analysis pipeline published by Singh and colleagues in the PLOS ONE [3]. The data generated in our work pro-
vide meaningful information for understanding the molecular mechanisms underlying the cholesterol-lowering
effects of ASE.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).SpeciﬁcationsOrganism/cell
line/tissueThe liver and ovary tissues of laying hens (Hy-Line Brown
hens)Sex Female
Sequencer or
array typeIllumina Hiseq 2000Data format Raw data: FASTQ ﬁles
Experimental
factorsFed with ASE based on basal diet vs. a basal diet with no ASEExperimental
featuresThe liver and ovary tissues of laying hens were collected and
digital gene expression (DGE) was performed to investigate
the mechanisms underlying the cholesterol-lowering effect of
ASE.Consent N/A
Sample source
locationAll animal experiments were approved by the Animal Care
and Use Committee of Henan Agricultural University. ASE was
provided by Hebei Bao'en Biotechnology Co., Ltd.
(Shijiazhuang, China)ollege of Animal Science and
ngzhou, Henan 450002, China.
q@126.com (H. Du),
P. Shi), wangcz@henau.edu.cn
. This is an open access article underDirect link to deposited data
Deposited data can be found here:
http://www.ncbi.nlm.nih.gov/biosample?Db=biosample&
DbFrom=bioproject&Cmd=Link&LinkName=bioproject_biosample&
LinkReadableName=BioSample&ordinalpos=1&IdsFromResult=
240129
Experimental design, materials and methods
Experimental design
Cardiovascular disease is a major cause of death worldwide, so
people are advised to limit their intake of dietary cholesterol [1]. Egg
consumption has been seriously reduced because of the high levels of
cholesterol [2]. ASE can modulate cholesterol metabolism and decrease
cholesterol levels in animals. In this study, the liver and ovary tissues of
laying hens were collected and digital gene expression (DGE) was per-
formed to investigate the mechanisms underlying the cholesterol-
lowering effect of ASE. 150 Hy-Line Brown hens at the age of
27 weeks were randomly divided into ﬁve groups (ﬁve replicates
were established per treatment, with 6 hens each replicate). Hens in
each treatment were randomly fed ﬁve different experimental diets:
Controls were fed a basal diet with 0 mg/kg ASE, and the other four
groups were fed otherwise identical diets supplemented with 60
mg/kg, 120 mg/kg, 240 mg/kg, and 480 mg/kg ASE, respectively. The
basal diet was designed to meet, or exceed, the National Research
Council (NRC) nutrient requirements. The ingredients and calculatedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Composition and nutrient content of diet.
Ingredient % Nutrient levelb
Corn 69.70 Crude protein (%) 16.50
Soybean meal 14.45 Calcium (%) 3.44
Limestone power 8.50 Phosphorus (%) 0.59
Peruvian ﬁshmeal 4.96 Available phosphorus (%) 0.42
Dicalcium phosphate 1.00 Lysine (%) 0.83
Salt 0.20 Methionine (%) 0.38
Choline chloride 0.10 Methionine + cysteine (%) 0.63
DL-methionine 0.09 Apparent metabolic energy
(MJ/kg)
11.49
Trace mineral and vitamin
premixa
1.00
a Premix provided the following per kilogram of diet: 60 mg of iron, 80 mg of manga-
nese, 8 mg of copper, 80 mg of zinc, 1 mg of iodine, 0.3 mg of selenium, 12,200 IU of vita-
min A, 4125 IU of vitaminD3, 30 IU of vitamin E, 4.5mg of vitamin K, 5mg of vitamin B12, 2
mg of biotin, 5 mg of folic acid, 32.5 mg of niacin, 5.3 mg of pantothenic acid, 8 mg of pyr-
idoxine, 8.5 mg of riboﬂavin, and 1 mg of thiamine.
b Obtained by calculation.
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ed by Hebei Bao'en Biotechnology Co., Ltd. (Shijiazhuang, China) as a
standardized product that contained 61.64% saponins, 10.97% ﬂavo-
noids, 8.12% polysaccharides, 7.11% moisture, and 12.16% unknown
compounds. ASE is extracted from Medicago sativa L. The main active
component is saponins. And ASE played a positive role in lowering
yolk cholesterol content [4–6]. According to the cholesterol levels in
yolk of feeding experiment, the control group and 120 mg/kg ASE
group were chosen for digital gene-expression proﬁling analysis
(Table 2) [3]. The liver and ovary tissues of 120 mg/kg ASE group were
isolated, frozen immediately in liquid nitrogen and stored at −80 °C
until RNA extraction (the liver from the control group (Li_CK), the
liver from the 120mg/kg ASE group (Li_Exp), the ovaries from the con-
trol group (Ov_CK), the ovaries from the 120 mg/kg ASE group
(Ov_Exp)).
Total RNA isolation
Total RNA was isolated using the Trizol reagent (Invitrogen, Code
No.: 15596-018) according to the manufacturer's instructions. RNA
degradation and contamination were monitored on 1% agarose gels.
RNA was assessed for quantity and quality using a Nanodrop ND-1000
spectrophotometer and Agilent 2100 Bioanalyzer according to the
manufacturer's instructions. Contaminating genomic DNA in total RNA
samples were treated with DNase-I.
Generation of sequencing data
2 μg of total RNA (≥100 ng/μL) was pooled from three tissues
within each group: Li_CK, Li_Exp, Ov_CK, Ov_Exp. Four sequencing
libraries were generated using NEB Next Ultra Directional RNA
Library Prep Kit for Illumina (NEB) in accordance with the
manufacturer's recommendations. MRNA was puriﬁed from total
RNA using poly-T oligo-attached magnetic beads (Life technologies,
CA, USA). Fragmentation was carried out using divalent captions
under elevated temperature in NEB proprietary fragmentationTable 2
Dietary ASE and concentrations of yolk cholesterol (mg/g).
Parameter period ASE in diet (mg/kg)
0 60
Day 15 8.89 ± 0.21 8.20 ± 0.41
Day 30 9.23 ± 0.24a 8.22 ± 0.25b
Day 45 9.33 ± 0.24a 9.09 ± 0.26ab
Day 60 9.57 ± 0.41a 9.37 ± 0.25ab
a,bMeans in the same row not sharing a common superscript differ signiﬁcantly at P b 0.05.buffer. First strand cDNA was synthesized using random oligonucle-
otides and M-Mel Reverse Transcriptase (RNase H-). Second strand
cDNA synthesis was subsequently performed using DNA polymerase
I and RNase H. Remaining overhangs were converted into blunt ends
via exonuclease/polymerase activities and enzymes were removed.
After adenylation of 3′ ends of DNA fragments, NEB Next adaptor
oligonucleotides were ligated to cDNA fragments. In order to select
cDNA fragments. DNA fragments with ligated adaptor molecules on
both ends were selectively enriched using NEB Universal PCR Primer
and Index primer in a 10 cycles PCR reaction. Products were puriﬁed
and quantiﬁed using the Agilent high sensitivity DNA assay on the
Agilent Bioanalyzer 2100 system. After the clustering of the index-
coded samples, each library preparation was sequenced on an
Illumina HiSeq 2000 platform and 50 bp single-end (SE) reads
were generated.
Mapping and analysis of DGE reads
For each DGE library, clean tags were obtained by ﬁltering out
adaptor sequences and low-quality tags. Then the clean tags were
retained and mapped to the reference genome of Gallus gallus at
ftp://ftp.ensembl.org/pub/release-72/fasta/gallus_gallus/dna by
TopHat v1.4.0 [7]. HTSeq v0.5.3 was used to count the reads mapped
to each gene [8]. Then reads per kilobase transcriptome per million
mapped reads (RPKM) of each gene were calculated based on the
length of the gene and reads count mapped to this gene. It is cur-
rently the most common method of for estimating levels of gene
expression [9]. In order to balance the number of false positives
and false negatives a RPKM threshold value of 0.3 was established
to determine whether or not given genes was expressed, as in
several other studies [10–12]. Differential expression analysis of
two conditions was performed using the DEGSeq R package
v1.12.0 [13]. P-values were adjusted using Q-value. [14]. The Q-
values of 0.05 and log2 (Fold_change) with no limitations were
served as the threshold of signiﬁcance for differential expression.
Here, 110 signiﬁcantly expressed genes were identiﬁed in liver sam-
ples; 66 were up-regulated and 44 were down-regulated. In ovary
samples, 107 signiﬁcantly expressed genes were obtained; 63
were up-regulated and 44 were down-regulated (Table S1) [3].
Gene Ontology (GO) enrichment analysis of differentially expressed
genes was implemented by the GOseq R package [15]. We used
KOBAS software to test the statistical enrichment of differential
expression genes in KEGG pathways [16,17]. KEGG pathway analy-
sis of differently expressed genes was also performed (Table S2)
[3]. Protein interaction networks of differentially expressed genes
were acquired based on the information in STRING database
(http://string-db.org/). Cytoscape software was used to visualize
the interaction networks [18]. The process of DGE analysis was
depicted in Fig. 1.
Discussion
Based on the supplementing 120mg/kg ASE played a positive role in
lowering yolk cholesterol content [3], the group with 120 mg/kg ASE
was used for digital gene-expression proﬁling analysis. In this study,120 240 480
8.27 ± 0.07 8.46 ± 0.31 8.49 ± 0.19
8.35 ± 0.59b 8.49 ± 0.61b 8.49 ± 0.13b
8.78 ± 0.32b 8.87 ± 0.11b 9.02 ± 0.46ab
8.89 ± 0.45b 9.47 ± 0.39ab 9.31 ± 0.36ab
Fig. 1. The process of DGE analysis.
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metabolism. In order to shedmore light on the functional roles of differ-
entially expressed genes responsible for the cholesterol-lowering effect
of ASE, functional annotation was investigated using GO classiﬁcation
and KEGG pathway analysis between Ov_CK and Ov_Exp samples [3].
Our results provided that ASEwere partially mediated by enhancement
of cholesterol efﬂux in the liver and this reduced of cholesterol deposi-
tion in the ovary.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gdata.2014.12.003.
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